Trial · NCT04533737
Adverse events38
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 38
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Arm 1 (Brodalumab + Dummy 1) | 10 | 56 | 14 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Arm 2 (Guselkumab + Dummy 2) | 2 | 56 | 4 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Arm 1 (Brodalumab + Dummy 1) | 5 | 56 | 5 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Arm 2 (Guselkumab + Dummy 2) | 1 | 56 | 1 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Arm 1 (Brodalumab + Dummy 1) | 4 | 56 | 4 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Arm 2 (Guselkumab + Dummy 2) | 0 | 56 | 0 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Arm 1 (Brodalumab + Dummy 1) | 3 | 56 | 4 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Arm 2 (Guselkumab + Dummy 2) | 0 | 56 | 0 |
| other | COVID-19 | Infections and infestations | Arm 1 (Brodalumab + Dummy 1) | 8 | 56 | 8 |
| other | COVID-19 | Infections and infestations | Arm 2 (Guselkumab + Dummy 2) | 6 | 56 | 6 |
| other | Nasopharyngitis | Infections and infestations | Arm 1 (Brodalumab + Dummy 1) | 7 | 56 | 7 |
| other | Nasopharyngitis | Infections and infestations | Arm 2 (Guselkumab + Dummy 2) | 4 | 56 | 4 |
| other | Psoriasis | Skin and subcutaneous tissue disorders | Arm 1 (Brodalumab + Dummy 1) | 3 | 56 | 3 |
| other | Psoriasis | Skin and subcutaneous tissue disorders | Arm 2 (Guselkumab + Dummy 2) | 0 | 56 | 0 |
| other | Dyspepsia | Gastrointestinal disorders | Arm 1 (Brodalumab + Dummy 1) | 3 | 56 | 3 |
| other | Dyspepsia | Gastrointestinal disorders | Arm 2 (Guselkumab + Dummy 2) | 0 | 56 | 0 |
| other | Fatigue | General disorders | Arm 1 (Brodalumab + Dummy 1) | 2 | 56 | 2 |
| other | Fatigue | General disorders | Arm 2 (Guselkumab + Dummy 2) | 3 | 56 | 3 |
| other | Headache | Nervous system disorders | Arm 1 (Brodalumab + Dummy 1) | 5 | 56 | 10 |
| other | Headache | Nervous system disorders | Arm 2 (Guselkumab + Dummy 2) | 3 | 56 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04533737/events